Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 19,956 shares at $9.70 ($194K) on 2021-06-04, disclosed to the SEC on 2021-06-08.
Open-market sale of $194k PRTK by Chief Development & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.70 | 9,978 | $97K | 50.0% |
| 2 | $9.70 | 9,978 | $97K | 50.0% |
| Total | $9.70 avg | 19,956 | $194K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $58K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |